VenoStent, Inc.
Private Company
Developing bioresorbable smart polymer scaffolds to transform vascular surgery
Medical Device
Houston, TX
11-50 employees
Founded 2017
About VenoStent, Inc.
VenoStent is a medical device company focused on making arteriovenous (AV) access surgery for hemodialysis work the first time. It develops SelfWrap, a bioabsorbable vascular wrap that acts as an external stent to improve the usability and success rate of AV fistulas. The company's primary customers are healthcare providers, including vascular surgeons and hospitals, who treat patients with chronic kidney disease.
Company Classification
Customer Types
B2B
Business Models
Products
Product & Service Types
Bioabsorbable vascular wrapsMedical devices for dialysis access surgery
Funding
Total Funding
$29.82M
No. of Funding Rounds
12
Customers
| Customer | Success Story | Source |
|---|---|---|
| Participated in VenoStent's SAVE-FistulaS Clinical Trial, with Dr. Eric Peden, Chief of Vascular Surgery, serving as the National Principal Investigator. The hospital has collaborated with VenoStent since 2018 on NIH- and NSF‑funded studies. | ||
| Enrolled subjects at their Austin, Texas location in VenoStent's SAVE-FistulaS Clinical Trial, utilizing the SelfWrap Bioabsorbable Perivascular Wrap to improve outcomes from arteriovenous fistula creation surgery. | ||
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos